# Pharmacokinetics of Cobitolimod Enemas in Participants With Active Ulcerative Colitis

> **NCT05404074** · PHASE1 · UNKNOWN · sponsor: **InDex Pharmaceuticals** · enrollment: 6 (estimated)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DRUG:** Cobitolimod 500mg

## Key facts

- **NCT ID:** NCT05404074
- **Lead sponsor:** InDex Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-22
- **Primary completion:** 2022-10-15
- **Final completion:** 2022-10-30
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2022-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05404074

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05404074, "Pharmacokinetics of Cobitolimod Enemas in Participants With Active Ulcerative Colitis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05404074. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*